Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | FTO | Q9C0B1 | 2/20 | 0.40 |
| ▸ | ALOX15 | P16050 | 4/20 | 0.32 |
| ▸ | ALOX12 | P18054 | 2/20 | 0.32 |
| ▸ | RXRA | P19793 | 2/20 | 0.32 |
| ▸ | MAOB | P27338 | 1/20 | 0.32 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.31 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.31 |
| ▸ | BCHE | P06276 | 1/20 | 0.30 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.30 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.30 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.30 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.30 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.30 |
| ▸ | EHMT2 | Q96KQ7 | 2/20 | 0.30 |
| ▸ | NFKB1 | P19838 | 1/20 | 0.30 |
| ▸ | NFKB2 | Q00653 | 1/20 | 0.30 |
| ▸ | RELA | Q04206 | 1/20 | 0.30 |
| ▸ | P4HB | P07237 | 1/20 | 0.30 |
| ▸ | MAPT | P10636 | 1/20 | 0.30 |
| ▸ | CA12 | O43570 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL19398980 | 0.88 | FTO (0.39) | FTO | |
| SCHEMBL13250932 | 0.87 | FTO (0.33) | FTORXRAALDH1A1MAPK1EHMT2 | |
| SCHEMBL13979784 | 0.83 | FTO (0.38) | FTORXRAMAOBALDH1A1BCHE | |
| SCHEMBL12110373 | 0.83 | FTO (0.38) | FTORXRAMAOBALDH1A1MAPT | |
| SCHEMBL11136773 | 0.82 | CA12 (0.41) | FTOALOX15ALOX12RXRAALDH1A1 | |
| SCHEMBL13452900 | 0.81 | FTO (0.32) | FTOALDH1A1MAPK1 | |
| SCHEMBL4464547 | 0.81 | FTO (0.39) | FTOALOX15RXRAMAOBALDH1A1 | |
| SCHEMBL21730011 | 0.80 | FTO (0.38) | FTOALOX15ALOX12ALDH1A1MAPK1 | |
| SCHEMBL10001257 | 0.79 | MAPKAPK2 (0.33) | FTOALOX12 | |
| SCHEMBL751889 | 0.79 | NQO2 (0.36) | MAPT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8969628-B2 | Method for enriching a homogeneous catalyst from a process flow | EVONIK DEGUSSA GMBH (DE) | 2015-03-03 | — | — | US | disclosed |
| US-20120046503-A1 | METHOD FOR ENRICHING A HOMOGENEOUS CATALYST FROM A PROCESS FLOW | EVONIK OXENO GMBH (DE) | 2012-02-23 | — | — | US | disclosed |
| US-8056732-B2 | Microporous polymer material | THE UNIVERSITY OF MANCHESTER (GB) | 2011-11-15 | — | — | US | disclosed |
| US-20100304112-A1 | MICROPOROUS POLYMER MATERIAL | THE UNIVERSITY OF MANCHESTER (GB) | 2010-12-02 | — | — | US | disclosed |
| US-7690514-B2 | Microporous polymer material | THE UNIVERSITY OF MANCHESTER (GB) | 2010-04-06 | — | — | US | disclosed |
| US-7410525-B1 | Mixed matrix membranes incorporating microporous polymers as fillers | UOP LLC (US) | 2008-08-12 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20120046503-A1 | METHOD FOR ENRICHING A HOMOGENEOUS CATALYST FROM A PROCESS FLOW | PARG, PHOSPHO1, COG6 | FTO 229/4885ALOX15 1054/4885ALOX12 1767/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.